Apoptosis: Pathophysiology and therapeutic implications for the cardiac surgeon

Annals of Thoracic Surgery

Volumn 78, Issue 3, 2004, Pages 1109-1118

  Khoynezhad, Ali ^a,c   Jalali, Ziba ^b   Tortolani, Anthony J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

31

Indexed keywords

ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CASPASE INHIBITOR; CATECHOLAMINE; PHOSPHODIESTERASE INHIBITOR; SOMATOMEDIN C;

APOPTOSIS; CARDIOTOXICITY; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEART VALVE REPLACEMENT; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; CASPASES; ENZYME ACTIVATION; HEART FAILURE, CONGESTIVE; HUMANS; MITOCHONDRIA; MUSCLE CELLS; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; REPERFUSION INJURY;

EID: 4444383358     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.06.034     Document Type: Review

References (82)

1. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257
2. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462
3. Nicholson D.W., Thornberry N.A. Caspases killer proteases. Trends Biochem Sci. 22:1997;299-306
4. Brunet C.L., Gunby R.H., Benson R.S., Hickman J.A., Watson A.J., Brady G. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ. 5:1998;107-115
5. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312
6. Jiang L., Huang Y., Yuasa T., Hunyor S., dos Remedios C.G. Elevated DNase activity and caspase expression in association with apoptosis in failing ischemic sheep left ventricles. Electrophoresis. 20:1999;2046-2052
7. Narula J., Pandey P., Arbustini E., et al. Apoptosis in heart failure release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA. 96:1999;8144-8149
8. Li P., Nijhawan D., Budihardjo I., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489
9. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts requirement for dATP and cytochrome c. Cell. 86:1996;147-157
10. Koglin J., Granville D.J., Glysing-Jensen T., et al. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. Circulation. 99:1999;836-842
11. Misao J., Hayakawa Y., Ohno M., Kato S., Fujiwara T., Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 94:1996;1506-1512
12. Liu L., Azhar G., Gao W., Zhang X., Wei J.Y. Bcl-2 and Bax expression in adult rat hearts after coronary occlusion age-associated differences. Am J Physiol. 275:1998;R315-322
13. Condorelli G., Morisco C., Stassi G., et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation. 99:1999;3071-3078
14. Deveraux Q.L., Reed J.C. IAP family proteins - suppressors of apoptosis. Genes Dev. 13:1999;239-252
15. Kubota T., McTiernan C.F., Frye C.S., et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 81:1997;627-635
16. Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., Lenardo M.J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377:1995;348-351
17. Srinivasula S.M., Ahmad M., Ottilie S., et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem. 272:1997;18542-18545
18. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50
19. Krown K.A., Page M.T., Nguyen C., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 98:1996;2854-2865
20. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141
21. Olivetti G., Quaini F., Sala R., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol. 28:1996;2005-2016
22. Geng Y.J., Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol. 147:1995;251-266
23. Bachmaier K., Pummerer C., Kozieradzki I., et al. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation. 95:1997;655-661
24. Szabolcs M., Michler R.E., Yang X., et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation. 94:1996;1665-1673
25. James T.N., St Martin E., Willis P.W. III, Lohr T.O. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation. 93:1996;1424-1438
26. Cheng W., Kajstura J., Nitahara J.A., et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 226:1996;316-327
27. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281
28. Armstrong RC, Li F, Smiley R, Armer N. Caspase inhibitors reduce infarct size when dosed post-perfusion in a rodent cardiac ischemia/reperfusion model. Circulation 2001;104:II-12
29. Abbate A., Biondi-Zoccai G., Baldi F. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol. 193:2002;145-153
30. Li Q., Li B., Wang X., et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest. 100:1997;1991-1999
31. Oskarsson H.J., Coppey L., Weiss R.M., Li W.G. Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction. Cardiovasc Res. 45:2000;679-687
32. Dhalla N.S., Elmoselhi A.B., Hata T., Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 47:2000;446-456
33. Zhao Z.Q., Nakamura M., Wang N.P., et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res. 45:2000;651-660
34. Grech E.D., Dodd N.J., Jackson M.J., Morrison W.L., Faragher E.B., Ramsdale D.R. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol. 77:1996;122-127
35. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Apoptosis in relevant clinical situations contribution of apoptosis in myocardial infarction. Cardiovasc Res. 45:2000;630-641
36. Thiemermann C., Bowes J., Myint F.P., Vane J.R. Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA. 94:1997;679-683
37. Yellon D.M., Alkhulaifi A.M., Pugsley W.B. Preconditioning the human myocardium. Lancet. 342:1993;276-277
38. Przyklenk K., Kloner R.A. Ischemic preconditioning exploring the paradox. Prog Cardiovasc Dis. 40:1998;517-547
39. Brocheriou V., Hagege A.A., Oubenaissa A., et al. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med. 2:2000;326-333
40. Maulik N., Engelman R.M., Rousou J.A., Flack J.E. III, Deaton D., Das D.K. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation. 100:(Suppl 2):1999;369-375
41. Jenkins D.P., Pugsley W.B., Alkhulaifi A.M., Kemp M., Hooper J., Yellon D.M. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart. 77:1997;314-318
42. Perrault L.P., Menasche P., Bel A., et al. Ischemic preconditioning in cardiac surgery a word of caution. J Thorac Cardiovasc Surg. 112:1996;1378-1386
43. Bolli R. Basic and clinical aspects of myocardial stunning. Prog Cardiovasc Dis. 40:1998;477-516
44. Bolli R. Myocardial 'stunning' in man. Circulation. 86:1992;1671-1691
45. Ballantyne C.M., Verani M.S., Short H.D., Hyatt C., Noon G.P. Delayed recovery of severely "stunned" myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgery. J Am Coll Cardiol. 10:1987;710-712
46. Breisblatt W.M., Stein K.L., Wolfe C.J., et al. Acute myocardial dysfunction and recovery a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 15:1990;1261-1269
47. Bolli R., Hartley C.J., Chelly J.E., et al. An accurate, nontraumatic ultrasonic method to monitor myocardial wall thickening in patients undergoing cardiac surgery. J Am Coll Cardiol. 15:1990;1055-1065
48. Wicomb W.N., Cooper D.K., Novitzky D., Barnard C.N. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. Ann Thorac Surg. 37:1984;243-248
49. Deantonio H.J., Kaul S., Lerman B.B. Reversible myocardial depression in survivors of cardiac arrest. Pacing Clin Electrophysiol. 13:1990;982-985
50. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628
51. Orrenius S., McConkey D.J., Bellomo G., Nicotera P. Role of Ca2+ in toxic cell killing. Trends Pharmacol Sci. 10:1989;281-285
52. Sun J.Z., Kaur H., Halliwell B., Li X.Y., Bolli R. Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. Circ Res. 73:1993;534-549
53. Przyklenk K., Kloner R.A. Effect of verapamil on postischemic "stunned" myocardium importance of the timing of treatment. J Am Coll Cardiol. 11:1988;614-623
54. Wijns W., Vatner S.F., Camici P.G. Hibernating myocardium. N Engl J Med. 339:1998;173-181
55. Dispersyn G.D., Borgers M., Flameng W. Apoptosis in chronic hibernating myocardium sleeping to death? Cardiovasc Res. 45:2000;696-703
56. Sheng Z., Knowlton K., Chen J., Hoshijima M., Brown J.H., Chien K.R. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem. 272:1997;5783-5791
57. Li Z., Bing O.H., Long X., Robinson K.G., Lakatta E.G. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol. 272:1997;H2313-2319
58. Teiger E., Than V.D., Richard L., et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 97:1996;2891-2897
59. Cheng W., Li B., Kajstura J., et al. Stretch-induced programmed myocyte cell death. J Clin Invest. 96:1995;2247-2259
60. Kajstura J., Cigola E., Malhotra A., et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol. 29:1997;859-870
61. Leri A., Claudio P.P., Li Q., et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 101:1998;1326-1342
62. Wu C.F., Bishopric N.H., Pratt R.E. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem. 272:1997;14860-14866
63. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189
64. Communal C., Singh K., Pimentel D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation. 98:1998;1329-1334
65. Rossig L., Haendeler J., Mallat Z., et al. Congestive heart failure induces endothelial cell apoptosis protective role of carvedilol. J Am Coll Cardiol. 36:2000;2081-2089
66. Romeo F., Li D., Shi M., Mehta J.L. Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res. 45:2000;788-794
67. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 334:1996;1349-1355
68. Lechat P., Packer M., Chalon S., Cucherat M., Arab T., Boissel J.P. Clinical effects of beta-adrenergic blockade in chronic heart failure a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 98:1998;1184-1191
69. Katz A.M. Cell death in the failing heart role of an unnatural growth response to overload. Clin Cardiol. 18:(Suppl 4):1995;36-44
70. Reiss K., Capasso J.M., Huang H.E., Meggs L.G., Li P., Anversa P. ANG II receptors, c-myc, and c- jun in myocytes after myocardial infarction and ventricular failure. Am J Physiol. 264:1993;H760-769
71. Garg R., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 273:1995;1450-1456
72. Sharma D., Buyse M., Pitt B., Rucinska E.J. Meta-analysis of observed mortality data from all-controlled, double- blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group. Am J Cardiol. 85:2000;187-192
73. Mann D.L., Kent R.L., Parsons B., Cooper G.T. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:1992;790-804
74. Humphreys R.A., Haist J.V., Chakrabarti S., Feng Q., Arnold J.M., Karmazyn M. Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. Am J Physiol. 276:1999;H749-757
75. Packer M., O'Connor C.M., Ghali J.K., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med. 335:1996;1107-1114
76. Cohn J.N., Ferrari R., Sharpe N. Cardiac remodeling - concepts and clinical implications a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 35:2000;569-582
77. Kawahito K., Misawa Y., Fuse K. Transient rise in serum soluble Fas (APO-1/CD95) in patients undergoing cardiac surgery. Artif Organs. 24:2000;628-631
78. Baumgartner W.A., Walinsky P.L., Salazar J.D., et al. Assessing the impact of cerebral injury after cardiac surgery will determining the mechanism reduce this injury? Ann Thorac Surg. 67:1999;1871-1874
79. Meldrum D.R., Donnahoo K.K. Role of TNF in mediating renal insufficiency following cardiac surgery evidence of a postbypass cardiorenal syndrome. J Surg Res. 85:1999;185-199
80. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 345:2001;1435-1443
81. Haunstetter A., Izumo S. Future perspectives and potential implications of cardiac myocyte apoptosis. Cardiovasc Res. 45:2000;795-801
82. Colucci W.S., Sawyer D.B., Singh K., Communal C. Adrenergic overload and apoptosis in heart failure implications for therapy. J Card Fail. 6:(Suppl 1):2000;1-7